Complete remission achieved in a case of both primary and recurrent adult acute myelogeneous leukemia by a novel nutritional therapy

The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy
Peter Grandics

Abstract

The aim of this study was to determine the possible clinical benefit of molasses-based dietary compositions (designated as MSQ 13, MSQ 15, and MSQ 18) in a case of both primary and recurrent adult AML. The design was a single case study. The setting was in the home. The regime of dietary compositions initially was administered as follows: MSQ-13 1 tbsp t.i.d. for 1 mo, MSQ-15 2 tbsp t.i.d. for 3 mo. After recurrence, MSQ-18 was taken at 2 tbsp t.i.d. for 3 mo. Clinical improvement and regression of AML were the outcome measures. Treatment with the MSQ dietary compositions resulted in disease regression and the reversal of clinical manifestations over two episodes of AML. Therefore, further studies are warranted to evaluate the utility of this approach for the clinical management of AML.

References

Jun 12, 2002·Current Treatment Options in Oncology·L D Cripe, S Hinton
Jul 19, 2002·Archives of Internal Medicine·Joseph MenzinRajiv Mallick
Nov 20, 2003·Journal of Carcinogenesis·Peter Grandics

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.